Abstract
The liver is a common site of metastases from several of the most prevalent human malignancies, in particular cancers of the gastrointestinal tract such as colorectal (CRC), neuroendocrine, pancreatic, esophageal and gastric carcinomas. For CRC, over 50% of patients will present with liver metastases either at the time of diagnosis or after resection of the primary tumor [1].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Alberts SR, Wagman LD (2008) Chemotherapy for colorectal cancer liver metastases. Oncologist 13:1063–1073
Selzner M et al (2000) Liver metastases from breast cancer: long-term survival after curative resection. Surgery 127:383–389
Lubrano J et al (2008) Liver resection for breast cancer metastasis: does it improve survival? Surg Today 38:293–299
Ercolani G et al (2005) The role of liver resections for noncolorectal, nonneuroendocrine metastases: experience with 142 observed cases. Ann Surg Oncol 12:459–466
Goldberg RM et al (2007) The continuum of care: a paradigm for the management of metastatic colorectal cancer. Oncologist 12:38–50
Jaeck D, Pessaux P (2008) Bilobar colorectal liver metastases: treatment options. Surg Oncol Clin N Am 17:553–568, ix
Benoist S, Nordlinger B (2009) The role of preoperative chemotherapy in patients with resectable colorectal liver metastases. Ann Surg Oncol 16:2385–2390
Brooks SA et al (2009) Molecular interactions in cancer cell metastasis. Acta Histochem 112:3–25
Steeg PS (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12:895–904
Bissell MJ, Kenny PA, Radisky DC (2005) Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes. Cold Spring Harb Symp Quant Biol 70:1–14
Robinson SC, Coussens LM (2005) Soluble mediators of inflammation during tumor development. Adv Cancer Res 93:159–187
Coussens L, Werb Z (2002) Inflammation and cancer. Nature 420:860–867
Paget S (1989) The distribution of secondary growths in cancer of the breast. Cancer Metastasis Rev 8:98–101
Fidler IJ (2003) The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 3:453–458
Greenway CV, Stark RD (1971) Hepatic vascular bed. Physiol Rev 51:23–65
Acknowledgement
The author wishes to thank the McGill University Health Center Foundation and the Stewart family for the Stewart Fellowship in Research in Haematology and Oncology.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Brodt, P. (2011). Introduction. In: Brodt, P. (eds) Liver Metastasis: Biology and Clinical Management. Cancer Metastasis - Biology and Treatment, vol 16. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0292-9_1
Download citation
DOI: https://doi.org/10.1007/978-94-007-0292-9_1
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-0291-2
Online ISBN: 978-94-007-0292-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)